Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2012-01-20

European Medicines Agency recommends approval of new medicine for Cushing's disease

View source ↗

Summary

EMA recommends approval of a new medicine for Cushing's disease, indicating a potential new treatment option after evaluation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications